Haejun Song1, Jeongdeuk Lee2, Muhyung Lee3, Won Suk Choi4, Jung Hyun Choi5, Mi Suk Lee6, Mahdi Hashemi7, Emmanouil Rampakakis8, Kosuke Kawai9, Ron White10, Camilo Acosta10, John S Sampalis8, Hee Jin Cheong11. 1. Department of Dermatology, Korea University Guro Hospital, Seoul, Korea. 2. Department of Dermatology, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea. 3. Department of Dermatology, Kyung Hee University Medical Center, Seoul, Korea. 4. Division of Infectious Diseases, Department of Internal Medicine, Korea University Ansan Hospital, Kyunggido, Korea. 5. Division of Infectious Diseases, Department of Internal Medicine, The Catholic University of Korea, Incheon St. Mary's Hospital, Incheon, Korea. 6. Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center, Seoul, Korea. 7. JSS Medical Research, St-Laurent, Quebec, Canada. 8. JSS Medical Research, St-Laurent, Quebec, Canada; McGill University, Montreal, Quebec, Canada. 9. Temple University, Philadelphia, Pennsylvania, USA. 10. Merck & Co., West Point, Pennsylvania, USA. 11. Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, 97, Guro-dong gil, Guro-gu, Seoul, 152-703 Korea. Electronic address: heejinmd@korea.ac.kr.
Abstract
OBJECTIVES: To assess the herpes zoster (HZ) disease burden, including the severity and duration of HZ-associated pain, its impact on quality of life (QoL), and healthcare resource utilization (HCRU) in a South Korean clinical setting. METHODS: Patients aged ≥50 years were followed prospectively for ≤6 months. Based on the duration of their episode at enrollment, cases were classified as incident (<7 days) or prevalent (≥7 days). HZ pain and discomfort were measured with the HZ Severity of Illness (HZ-SOI) severity-by-duration composite score. RESULTS: One hundred fifty-one patients (69.5% prevalent cases) were enrolled. Prodrome pain was experienced by 68.2% of patients, of whom 95.1% experienced moderate-to-severe pain; post-herpetic neuralgia was experienced by 38.4%. Prevalent disease, higher acute pain, and older age were significant predictors of greater HZ-SOI, while use of antivirals was associated with decreased HZ-SOI. HZ-associated pain was associated with reduced QoL and affected all daily living activities (particularly mood, life enjoyment, general activities, and sleep), resulting in significant HCRU, including primary care doctor, specialist, or physiotherapist consultations, hospitalizations, and emergency department visits. CONCLUSION: Severe morbidity, impaired QoL, and significant HCRU are associated with HZ in South Korea, especially in older patients, supporting the need for early intervention and preventive strategies to reduce the HZ-associated disease burden.
OBJECTIVES: To assess the herpes zoster (HZ) disease burden, including the severity and duration of HZ-associated pain, its impact on quality of life (QoL), and healthcare resource utilization (HCRU) in a South Korean clinical setting. METHODS:Patients aged ≥50 years were followed prospectively for ≤6 months. Based on the duration of their episode at enrollment, cases were classified as incident (<7 days) or prevalent (≥7 days). HZ pain and discomfort were measured with the HZ Severity of Illness (HZ-SOI) severity-by-duration composite score. RESULTS: One hundred fifty-one patients (69.5% prevalent cases) were enrolled. Prodrome pain was experienced by 68.2% of patients, of whom 95.1% experienced moderate-to-severe pain; post-herpetic neuralgia was experienced by 38.4%. Prevalent disease, higher acute pain, and older age were significant predictors of greater HZ-SOI, while use of antivirals was associated with decreased HZ-SOI. HZ-associated pain was associated with reduced QoL and affected all daily living activities (particularly mood, life enjoyment, general activities, and sleep), resulting in significant HCRU, including primary care doctor, specialist, or physiotherapist consultations, hospitalizations, and emergency department visits. CONCLUSION: Severe morbidity, impaired QoL, and significant HCRU are associated with HZ in South Korea, especially in older patients, supporting the need for early intervention and preventive strategies to reduce the HZ-associated disease burden.
Authors: Hao Wang; Gary Romano; Margaret Fedgchin; Lucille Russell; Panna Sanga; Kathleen M Kelly; Mary Ellen Frustaci; John Thipphawong Journal: Clin J Pain Date: 2017-02 Impact factor: 3.442
Authors: Emmanouil Rampakakis; Melissa Stutz; Kosuke Kawai; Tsen-Fang Tsai; Hee Jin Cheong; Jittima Dhitavat; Alejandro Ortiz-Covarrubias; Miguel Cashat-Cruz; Homero Monsanto; Kelly D Johnson; John S Sampalis; Camilo J Acosta Journal: Health Qual Life Outcomes Date: 2017-01-18 Impact factor: 3.186
Authors: Won Suk Choi; Jung-Hyun Choi; Jun Yong Choi; Joong Sik Eom; Sang Il Kim; Hyunjoo Pai; Kyong Ran Peck; Jang Wook Sohn; Hee Jin Cheong Journal: J Korean Med Sci Date: 2015-12-24 Impact factor: 2.153